A Comprehensive Single-Cell and Spatial Analysis of Macrophage States in Human Atherosclerotic Plaques
-
By
-
Yuanyuan Yang
-
Haiying Zhu
-
April 29, 2026
-
Clinical Scorecard: A Comprehensive Single-Cell and Spatial Analysis of Macrophage States in Human Atherosclerotic Plaques
At a Glance
| Category | Detail |
| Condition | Atherosclerosis |
| Key Mechanisms | Macrophage heterogeneity and state programs linked to plaque behavior and clinical outcomes. |
| Target Population | Individuals with atherosclerosis, particularly those undergoing carotid endarterectomy. |
| Care Setting | Clinical settings involving cardiovascular risk assessment and intervention. |
Key Highlights
- Macrophages in atherosclerosis exhibit diverse states, including inflammatory and reparative phenotypes.
- Distinct macrophage states are associated with clinical features like symptomatic disease and plaque instability.
- Methodological heterogeneity in studies complicates cross-comparison and biological understanding.
- A coherent macrophage atlas can enhance risk stratification and therapeutic targeting.
- Spatial profiling reveals sex-dimorphic patterns in macrophage distribution and function.
Guideline-Based Recommendations
Diagnosis
- Utilize single-cell and spatial transcriptomic profiling to assess macrophage states in plaques.
Management
- Incorporate macrophage state signatures for personalized risk assessment and treatment strategies.
Monitoring & Follow-up
- Monitor changes in macrophage populations and states to predict cardiovascular events.
Risks
- Consider factors like symptom status, biological sex, and comorbidities in assessing plaque instability.
Patient & Prescribing Data
Patients with symptomatic and asymptomatic atherosclerosis undergoing vascular interventions.
Macrophage-targeted therapies may improve outcomes by addressing specific inflammatory profiles.
Clinical Best Practices
- Ensure rigorous tissue procurement protocols to maintain cellular viability and transcriptional fidelity.
- Employ spatially resolved approaches for accurate macrophage state mapping.
- Integrate clinical phenotyping with molecular profiling for comprehensive risk assessment.
References